Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVRIOS: Low vs High Dose Rifampicin in Staphylococcal Bone and Joint Infections
NCT02599493Phase 4Completed
- Sponsor
- CHU Rennes
- Start
- Jan 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifampicin in Staphylococcal osteoarticular infection, sponsored by CHU Rennes. Started Jan 2016; status: completed.
02
Drugs
rifampicin
03
Conditions
Staphylococcal osteoarticular infection
Beyond the preview
Go deeper on NCT02599493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02599493.